Sarah Israel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sarah Israel has a total of 460 co-authors. Here are the top co-authors by number of shared publications:
- Ariel Israel
Leumit Research Institute, Leumit Health Services, Tel-Aviv, Israel; Department of Epidemiology and Preventive Medicine, School of Public Health, Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel-Aviv, Israel
10 shared publications - Eli Magen
Adelson School of Medicine Ariel University Ariel Israel
7 shared publications - Abraham Weizman
Research Unit, Geha Mental Health Center, Felsenstein Medical Research Center, and Sagol School of Neurosciences, Faculty of Medical & Health Sciences, Tel Aviv University
6 shared publications - Eugene Merzon
Adelson School of Medicine, Ariel University, Ariel 4070000, Israel
6 shared publications - Shai Ashkenazi
Department of Morphological Sciences, Adelson School of Medicine, Ariel University, Ariel 4070000, Israel
6 shared publications - Shlomo Vinker
Department of Family Medicine, Faculty of Medicine, Tel Aviv University
5 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (10)
Vitamin D Deficiency, Supplementation, and Aging‐Related Morbidity and Mortality Across Two Longitudinal Population Cohorts
Vitamin D deficiency has been implicated in biological processes linked to aging and organismal resilience, yet its relationship to long‐term systemic aging trajectories remains incompletely characterized. We analyzed longitudinal electronic health record data from two large healthcare systems: Leumit Health Services (LHS), a nationwide Israeli health organization, and TriNetX, a federated US research network. We examined more than 1.67 million serum 25‐hydroxyvitamin D [25(OH)D] measurements from over 468,500 adults in LHS (2009–2020). Longitudinal matched analyses compared severe deficiency (< 10 ng/mL) with sufficiency (> 30 ng/mL) in LHS and were externally validated in 223,175 propensity score‐matched TriNetX pairs; matched cohorts were approximately 54 years old, 65%–67% female, and followed for up to 10 years. In both populations, severe deficiency was associated with increased risks across multiple aging‐related outcomes. All‐cause mortality was higher in LHS (adjusted HR 2.57, 95% CI 2.38–2.79) and TriNetX (HR 1.59, 1.55–1.63). To assess modifiability, we modeled vitamin D supplementation longitudinally using pharmacy‐dispensed purchases calibrated to predict serum 25(OH)D changes over time. Supplementation was independently associated with dose‐dependent reductions across mortality and multiple aging‐related outcomes; for > 10 ng/mL‐equivalent supplementation, mortality HR was 0.72 (0.68–0.76), while showing no corresponding association for skin malignancy. To strengthen causal interpretation, we additionally implemented inverse‐probability‐of‐treatment‐weighted marginal structural Cox models for mortality, which yielded results consistent with conventional adjusted models. Together, these findings support severe vitamin D deficiency as an important and potentially modifiable determinant of systemic aging vulnerability and age‐related multimorbidity in human populations.
- 8 October 2026
- Published by Wiley in Aging Cell
- Vol. 25 (10)
Open AccessVitamin D Deficiency, Supplementation, and Aging‐Related Morbidity and Mortality Across Two Longitudinal Population Cohorts
Vitamin D deficiency has been implicated in biological processes linked to aging and organismal resilience, yet its relationship to long‐term systemic aging trajectories remains incompletely characterized. We analyzed longitudinal electronic health record data from two large healthcare systems: Leumit Health Services (LHS), a nationwide Israeli health organization, and TriNetX, a federated US research network. We examined more than 1.67 million serum 25‐hydroxyvitamin D [25(OH)D] measurements from over 468,500 adults in LHS (2009–2020). Longitudinal matched analyses compared severe deficiency (< 10 ng/mL) with sufficiency (> 30 ng/mL) in LHS and were externally validated in 223,175 propensity score‐matched TriNetX pairs; matched cohorts were approximately 54 years old, 65%–67% female, and followed for up to 10 years. In both populations, severe deficiency was associated with increased risks across multiple aging‐related outcomes. All‐cause mortality was higher in LHS (adjusted HR 2.57, 95% CI 2.38–2.79) and TriNetX (HR 1.59, 1.55–1.63). To assess modifiability, we modeled vitamin D supplementation longitudinally using pharmacy‐dispensed purchases calibrated to predict serum 25(OH)D changes over time. Supplementation was independently associated with dose‐dependent reductions across mortality and multiple aging‐related outcomes; for > 10 ng/mL‐equivalent supplementation, mortality HR was 0.72 (0.68–0.76), while showing no corresponding association for skin malignancy. To strengthen causal interpretation, we additionally implemented inverse‐probability‐of‐treatment‐weighted marginal structural Cox models for mortality, which yielded results consistent with conventional adjusted models. Together, these findings support severe vitamin D deficiency as an important and potentially modifiable determinant of systemic aging vulnerability and age‐related multimorbidity in human populations.
- Open Access
- 13 August 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (8) , 606
Fluconazole Disk Diffusion on CHROMagar Candida Plus for Differentiation Between Candidozyma auris and Candida parapsilosis
Background: This study evaluated the utility of fluconazole disk diffusion on CHROMagar Candida Plus for differentiating Candidozyma auris from Candida parapsilosis. Methods: In this in vitro study, clinical isolates of both C. auris and C. parapsilosis were used. Antifungal susceptibility testing was performed via broth microdilution and disk diffusion with different fluconazole concentrations on both CHROMagar Candida Plus and RPMI agar. Colony color was also assessed. Results: This study demonstrates high categorical agreement between disk diffusion on CHROMagar Candida Plus and broth microdilution for both species. An optimal cut-off zone diameter of 10 mm was identified on CHROMagar Candida Plus with 50 µg fluconazole, providing 91% sensitivity and 90% specificity for differentiating the two species. Notably, at 24 h, 83 out of 88 (94.3%) C. auris isolates exhibited a bluish, blue-green, or turquoise coloration on the reverse side of the plate, suggesting that reverse-side colony color on CHROMagar may serve as a supportive phenotypic indicator when combined with disk diffusion testing, to differentiate C. auris from C. parapsilosis in the laboratory setting. Conclusions: Fluconazole disk diffusion on CHROMagar Candida Plus, supplemented by reverse-side colony coloration, offers a practical, low-cost adjunctive strategy to aid in the differentiation of C. auris and C. parapsilosis in clinical laboratories.
- 13 August 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (8) , 606
Open AccessFluconazole Disk Diffusion on CHROMagar Candida Plus for Differentiation Between Candidozyma auris and Candida parapsilosis
Background: This study evaluated the utility of fluconazole disk diffusion on CHROMagar Candida Plus for differentiating Candidozyma auris from Candida parapsilosis. Methods: In this in vitro study, clinical isolates of both C. auris and C. parapsilosis were used. Antifungal susceptibility testing was performed via broth microdilution and disk diffusion with different fluconazole concentrations on both CHROMagar Candida Plus and RPMI agar. Colony color was also assessed. Results: This study demonstrates high categorical agreement between disk diffusion on CHROMagar Candida Plus and broth microdilution for both species. An optimal cut-off zone diameter of 10 mm was identified on CHROMagar Candida Plus with 50 µg fluconazole, providing 91% sensitivity and 90% specificity for differentiating the two species. Notably, at 24 h, 83 out of 88 (94.3%) C. auris isolates exhibited a bluish, blue-green, or turquoise coloration on the reverse side of the plate, suggesting that reverse-side colony color on CHROMagar may serve as a supportive phenotypic indicator when combined with disk diffusion testing, to differentiate C. auris from C. parapsilosis in the laboratory setting. Conclusions: Fluconazole disk diffusion on CHROMagar Candida Plus, supplemented by reverse-side colony coloration, offers a practical, low-cost adjunctive strategy to aid in the differentiation of C. auris and C. parapsilosis in clinical laboratories.
- Open Access
- 10 August 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1757
Delayed Pathogenicity in Toxoplasma gondii as an Evolutionary Framework for Late-Life Disease and Mortality
Toxoplasma gondii infects most warm-blooded vertebrates and establishes lifelong persistence through latent bradyzoite cysts within long-lived tissues. We propose that this persistence may represent an evolved strategy of delayed pathogenicity. Because T. gondii completes sexual reproduction only in felids, most productively through ingestion of infected tissues, transmission may be favored by host impairments that increase vulnerability to predation or scavenging. However, pathogenic effects expressed too early could compromise host reproduction and reservoir maintenance. We therefore hypothesize that evolutionary pressures may favor pathogenic effects emerging predominantly later in host life, after reproduction has largely been achieved. Pharmacologic protozoal suppression has been associated with reduced mortality and multiple chronic diseases, while T. gondii DNA increases along the adenoma–carcinoma sequence in gastrointestinal malignancies. Together, these observations motivate a testable framework linking long-term parasite persistence to late-life morbidity.
- 10 August 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (8) , 1757
Open AccessDelayed Pathogenicity in Toxoplasma gondii as an Evolutionary Framework for Late-Life Disease and Mortality
Toxoplasma gondii infects most warm-blooded vertebrates and establishes lifelong persistence through latent bradyzoite cysts within long-lived tissues. We propose that this persistence may represent an evolved strategy of delayed pathogenicity. Because T. gondii completes sexual reproduction only in felids, most productively through ingestion of infected tissues, transmission may be favored by host impairments that increase vulnerability to predation or scavenging. However, pathogenic effects expressed too early could compromise host reproduction and reservoir maintenance. We therefore hypothesize that evolutionary pressures may favor pathogenic effects emerging predominantly later in host life, after reproduction has largely been achieved. Pharmacologic protozoal suppression has been associated with reduced mortality and multiple chronic diseases, while T. gondii DNA increases along the adenoma–carcinoma sequence in gastrointestinal malignancies. Together, these observations motivate a testable framework linking long-term parasite persistence to late-life morbidity.
- Open Access
- 30 March 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (4) , 780
Health Outcomes Associated with Asymptomatic Toxoplasma gondii Seropositivity in Young Adults: A Nationwide Matched Cohort Study
Toxoplasma gondii establishes latent infection in a substantial proportion of the global population, yet the long-term health consequences of this infection remain incompletely characterized. We conducted a retrospective observational matched cohort study using longitudinal electronic health record data from a nationwide integrated healthcare provider, including members aged 18–45 years who underwent routine Toxoplasma serologic screening, typically performed in obstetric evaluation, excluding patients with clinical toxoplasmosis, immunosuppression, or HIV. Seropositive individuals were matched 1:1 without replacement to seronegative controls to align demographic, temporal, and socioeconomic variables. Time-to-event associations with predefined medical conditions were evaluated using Cox proportional hazards models with false discovery rate correction. The final cohort included 19,443 seropositive individuals and 19,443 matched controls (96.7% female), with a tight baseline balance of demographic and temporal characteristics. During follow-up, seropositivity was associated with increased risks of tobacco dependence (aHR 1.65), alcohol dependence (2.32), suicide attempt (1.82), motor vehicle accidents (1.22), and work accidents (1.27), as well as multiple infectious conditions, including hepatitis B (1.55), hepatitis C (2.15), and syphilis (2.43), with an overall trend toward increased all-cause mortality (1.32, 95% CI [1.00–1.74]). These findings suggest that asymptomatic Toxoplasma infection in young adults is associated with increased long-term behavioral and medical comorbidity.
- 30 March 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (4) , 780
Open AccessHealth Outcomes Associated with Asymptomatic Toxoplasma gondii Seropositivity in Young Adults: A Nationwide Matched Cohort Study
Toxoplasma gondii establishes latent infection in a substantial proportion of the global population, yet the long-term health consequences of this infection remain incompletely characterized. We conducted a retrospective observational matched cohort study using longitudinal electronic health record data from a nationwide integrated healthcare provider, including members aged 18–45 years who underwent routine Toxoplasma serologic screening, typically performed in obstetric evaluation, excluding patients with clinical toxoplasmosis, immunosuppression, or HIV. Seropositive individuals were matched 1:1 without replacement to seronegative controls to align demographic, temporal, and socioeconomic variables. Time-to-event associations with predefined medical conditions were evaluated using Cox proportional hazards models with false discovery rate correction. The final cohort included 19,443 seropositive individuals and 19,443 matched controls (96.7% female), with a tight baseline balance of demographic and temporal characteristics. During follow-up, seropositivity was associated with increased risks of tobacco dependence (aHR 1.65), alcohol dependence (2.32), suicide attempt (1.82), motor vehicle accidents (1.22), and work accidents (1.27), as well as multiple infectious conditions, including hepatitis B (1.55), hepatitis C (2.15), and syphilis (2.43), with an overall trend toward increased all-cause mortality (1.32, 95% CI [1.00–1.74]). These findings suggest that asymptomatic Toxoplasma infection in young adults is associated with increased long-term behavioral and medical comorbidity.
- Open Access
- 25 March 2026
- Published by MDPI AG in Preprints.org
Delayed Virulence in Toxoplasma gondii as an Evolutionary Framework for Late-Life Disease and Mortality
Toxoplasma gondii infects most warm-blooded vertebrates and establishes lifelong persistence by encysting as latent bradyzoites within long-lived tissues, a state typically regarded as innocuous in immunocompetent hosts. We propose an alternative hypothesis: bradyzoite persistence may represent an evolved program of delayed virulence. Because T. gondii completes sexual reproduction only in felids after ingestion of infected tissues, parasite fitness is enhanced when infected tissues are consumed by felids. Host debilitation may increase vulnerability to predation or scavenging, but pathogenic effects expressed too early could jeopardize host populations; thus, selection should favor virulence that emerges after the host’s reproductive window, preserving population continuity. Multiple observations align with this hypothesis. Bradyzoite biology supports lifelong persistence across diverse host species. Pharmacologic suppression of protozoa has been associated with large and durable reductions in all-cause mortality and morbidity, including dementia, schizophrenia, and malignancy, across independent human cohorts. Viral coinfections provide plausible triggers for parasite reactivation. In parallel, T. gondii DNA increases progressively along the adenoma-to-carcinoma sequence in gastrointestinal malignancies. Together, these findings motivate a testable hypothesis: a fraction of late-life morbidity may reflect the delayed virulence of a parasite whose transmission is enhanced as hosts weaken. We present falsifiable predictions associated with this hypothesis.
- 25 March 2026
- Published by MDPI AG in Preprints.org
Open AccessDelayed Virulence in Toxoplasma gondii as an Evolutionary Framework for Late-Life Disease and Mortality
Toxoplasma gondii infects most warm-blooded vertebrates and establishes lifelong persistence by encysting as latent bradyzoites within long-lived tissues, a state typically regarded as innocuous in immunocompetent hosts. We propose an alternative hypothesis: bradyzoite persistence may represent an evolved program of delayed virulence. Because T. gondii completes sexual reproduction only in felids after ingestion of infected tissues, parasite fitness is enhanced when infected tissues are consumed by felids. Host debilitation may increase vulnerability to predation or scavenging, but pathogenic effects expressed too early could jeopardize host populations; thus, selection should favor virulence that emerges after the host’s reproductive window, preserving population continuity. Multiple observations align with this hypothesis. Bradyzoite biology supports lifelong persistence across diverse host species. Pharmacologic suppression of protozoa has been associated with large and durable reductions in all-cause mortality and morbidity, including dementia, schizophrenia, and malignancy, across independent human cohorts. Viral coinfections provide plausible triggers for parasite reactivation. In parallel, T. gondii DNA increases progressively along the adenoma-to-carcinoma sequence in gastrointestinal malignancies. Together, these findings motivate a testable hypothesis: a fraction of late-life morbidity may reflect the delayed virulence of a parasite whose transmission is enhanced as hosts weaken. We present falsifiable predictions associated with this hypothesis.
- 16 February 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (3) , 690-703
Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infection
The gut microbiome of people living with human immunodeficiency virus (PLWH) has been characterized, but its role in influencing host immunity and associated clinical features are unclear. Here we used shotgun metagenomics to characterize the faecal microbiome of two geographically distinct cohorts of PLWH and healthy controls in Israel and Ethiopia. We uncovered disease-specific, geographically divergent microbial patterns including a shift from Bacteroides to Prevotella species in an Israeli cohort and multiple Enterobacteriaceae species including Escherichia coli and Klebsiella quasivariicola in an Ethiopian cohort. We identified correlations between human immunodeficiency virus-related dysbiosis and the extent of systemic immunodeficiency, as proxied by peripheral CD4+ T cell counts. Faecal microbiome transplantation from PLWH with high peripheral CD4+ T cell counts induced colonic epithelium-associated CD4+ T cells in germ-free or antibiotic-treated recipient mice. Impaired epithelium-associated lymphocyte induction in recipients of faecal microbiome transplantation from severely immunodeficient PLWH donors was associated with altered protection from Cryptosporidium parvum infection. Collectively, our results suggest a link between systemic immunodeficiency and associated intestinal dysbiosis in PLWH, resulting in impaired gut mucosal immunity.
- 16 February 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (3) , 690-703
Human immunodeficiency virus-associated gut microbiome impacts systemic immunodeficiency and susceptibility to opportunistic gut infection
The gut microbiome of people living with human immunodeficiency virus (PLWH) has been characterized, but its role in influencing host immunity and associated clinical features are unclear. Here we used shotgun metagenomics to characterize the faecal microbiome of two geographically distinct cohorts of PLWH and healthy controls in Israel and Ethiopia. We uncovered disease-specific, geographically divergent microbial patterns including a shift from Bacteroides to Prevotella species in an Israeli cohort and multiple Enterobacteriaceae species including Escherichia coli and Klebsiella quasivariicola in an Ethiopian cohort. We identified correlations between human immunodeficiency virus-related dysbiosis and the extent of systemic immunodeficiency, as proxied by peripheral CD4+ T cell counts. Faecal microbiome transplantation from PLWH with high peripheral CD4+ T cell counts induced colonic epithelium-associated CD4+ T cells in germ-free or antibiotic-treated recipient mice. Impaired epithelium-associated lymphocyte induction in recipients of faecal microbiome transplantation from severely immunodeficient PLWH donors was associated with altered protection from Cryptosporidium parvum infection. Collectively, our results suggest a link between systemic immunodeficiency and associated intestinal dysbiosis in PLWH, resulting in impaired gut mucosal immunity.
- Open Access
- 11 August 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2545412
Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection
Emerging evidence suggests microbial pathogens contribute to digestive cancer risk. Atovaquone - proguanil (A-P), an antimalarial with antiparasitic activity, has been associated with a reduced risk of colorectal cancer (CRC). We conducted a retrospective cohort study using the TriNetX US Collaborative Network, including over 100,000 individuals aged 40-69 years who received A-P, matched 1:1 to controls who received other medications. Incident digestive cancers were analyzed using Cox proportional hazards models. Additionally, we performed a metagenomic analysis of 1,044 fecal samples from 156 individuals to assess the abundance of Toxoplasma gondii in CRC-associated microbiota. A-P use was associated with a significant reduction in digestive cancer incidence across all age groups: hazard ratios (HRs) ranged from 0.49 to 0.53 (all p < 0.001). Protective associations extended to pancreatic cancer (HR range, 0.50-0.72). In metagenomic analysis, T. gondii was the most discriminatory microbial species for CRC (p = 1.8 × 10-16), detected above threshold in 22.6% of CRC samples versus 1.6% of controls (odds ratio 18.2, 95% CI, 8.2-47.6, p = 2.3 × 10-22). These findings suggest T. gondii may be an overlooked microbial risk factor for digestive cancers, and that A-P may offer chemopreventive effects through antiparasitic activity. Prospective studies are needed to evaluate its preventive potential.
- 11 August 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2545412
Open AccessAtovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection
Emerging evidence suggests microbial pathogens contribute to digestive cancer risk. Atovaquone - proguanil (A-P), an antimalarial with antiparasitic activity, has been associated with a reduced risk of colorectal cancer (CRC). We conducted a retrospective cohort study using the TriNetX US Collaborative Network, including over 100,000 individuals aged 40-69 years who received A-P, matched 1:1 to controls who received other medications. Incident digestive cancers were analyzed using Cox proportional hazards models. Additionally, we performed a metagenomic analysis of 1,044 fecal samples from 156 individuals to assess the abundance of Toxoplasma gondii in CRC-associated microbiota. A-P use was associated with a significant reduction in digestive cancer incidence across all age groups: hazard ratios (HRs) ranged from 0.49 to 0.53 (all p < 0.001). Protective associations extended to pancreatic cancer (HR range, 0.50-0.72). In metagenomic analysis, T. gondii was the most discriminatory microbial species for CRC (p = 1.8 × 10-16), detected above threshold in 22.6% of CRC samples versus 1.6% of controls (odds ratio 18.2, 95% CI, 8.2-47.6, p = 2.3 × 10-22). These findings suggest T. gondii may be an overlooked microbial risk factor for digestive cancers, and that A-P may offer chemopreventive effects through antiparasitic activity. Prospective studies are needed to evaluate its preventive potential.
- Open Access
Antiprotozoal medications associated with increased longevity and reduced morbidity in two national cohorts
We conducted a stepwise pharmacoepidemiologic investigation, an unbiased medication-wide screen followed by matched cohort validation and external replication, to identify medications associated with longevity and aging-related morbidity. The initial screen, performed in a large national health system, identified two antiprotozoals, atovaquone-proguanil and mefloquine, as being associated with increased survival. Matched exposed-unexposed cohorts were then constructed to validate mortality associations and examine incident outcomes, revealing reduced risks for diabetes, dementia, cardiovascular, renal, hepatic, pulmonary, and selected cancers, alongside increased risks for hearing loss, dry eye/Sjogren’s, and lichen planus. These patterns were externally replicated in the US TriNetX network, where similar associations were observed for atovaquone-proguanil, mefloquine, and nirmatrelvir-ritonavir. Because nirmatrelvir-ritonavir is prescribed to older, multimorbid individuals, its associations are unlikely to reflect healthy-traveler conditioning. The concordant protective and tissue-specific adverse associations across datasets and antiprotozoal drug classes support a testable hypothesis: short antiprotozoal courses may reduce aging-related morbidity by decreasing persistent protozoal burden, particularly Toxoplasma gondii .
Open AccessAntiprotozoal medications associated with increased longevity and reduced morbidity in two national cohorts
We conducted a stepwise pharmacoepidemiologic investigation, an unbiased medication-wide screen followed by matched cohort validation and external replication, to identify medications associated with longevity and aging-related morbidity. The initial screen, performed in a large national health system, identified two antiprotozoals, atovaquone-proguanil and mefloquine, as being associated with increased survival. Matched exposed-unexposed cohorts were then constructed to validate mortality associations and examine incident outcomes, revealing reduced risks for diabetes, dementia, cardiovascular, renal, hepatic, pulmonary, and selected cancers, alongside increased risks for hearing loss, dry eye/Sjogren’s, and lichen planus. These patterns were externally replicated in the US TriNetX network, where similar associations were observed for atovaquone-proguanil, mefloquine, and nirmatrelvir-ritonavir. Because nirmatrelvir-ritonavir is prescribed to older, multimorbid individuals, its associations are unlikely to reflect healthy-traveler conditioning. The concordant protective and tissue-specific adverse associations across datasets and antiprotozoal drug classes support a testable hypothesis: short antiprotozoal courses may reduce aging-related morbidity by decreasing persistent protozoal burden, particularly Toxoplasma gondii .
- Open Access
Vitamin D Deficiency, Supplementation, and Aging-Related Morbidity and Mortality Across Two Longitudinal Population Cohorts
Vitamin D deficiency has been implicated in biological processes linked to aging and organismal resilience, yet its relationship to long-term systemic aging trajectories remains incompletely characterized. We analyzed longitudinal electronic health record data from two large healthcare systems: Leumit Health Services (LHS), a nationwide Israeli health organization, and TriNetX, a federated US research network containing de-identified electronic health records from over 120 million individuals. We examined more than 1.67 million serum 25-hydroxyvitamin D [25(OH)D] measurements from over 468,500 adults in LHS (2009-2020). Longitudinal matched analyses were performed in LHS, and associations involving severe deficiency were externally validated in 223,000 propensity score-matched pairs from TriNetX. In both populations, severe deficiency was associated with increased risks across metabolic, cardiovascular, neurodegenerative, renal, microvascular, and mortality-related outcomes, including diabetes mellitus, myocardial infarction, cerebrovascular disease, dementia, dialysis, diabetic retinopathy, and foot/toe amputation. To assess the potential health benefits and modifiability of supplementation, we modeled vitamin D supplementation longitudinally using pharmacy-dispensed purchases calibrated to predict serum 25(OH)D changes over time. Supplementation was independently associated with dose-dependent reductions across mortality and multiple aging-related outcomes, while showing no corresponding protective association for skin malignancy, a negative-control outcome strongly linked to ultraviolet exposure. To strengthen causal interpretation, we additionally implemented inverse-probability-of-treatment-weighted marginal structural Cox models for mortality, which yielded results consistent with, and in several cases stronger than, conventional adjusted models. Together, these findings support severe vitamin D deficiency as an important and potentially modifiable determinant of systemic aging vulnerability and age-related multimorbidity in human populations.
Open AccessVitamin D Deficiency, Supplementation, and Aging-Related Morbidity and Mortality Across Two Longitudinal Population Cohorts
Vitamin D deficiency has been implicated in biological processes linked to aging and organismal resilience, yet its relationship to long-term systemic aging trajectories remains incompletely characterized. We analyzed longitudinal electronic health record data from two large healthcare systems: Leumit Health Services (LHS), a nationwide Israeli health organization, and TriNetX, a federated US research network containing de-identified electronic health records from over 120 million individuals. We examined more than 1.67 million serum 25-hydroxyvitamin D [25(OH)D] measurements from over 468,500 adults in LHS (2009-2020). Longitudinal matched analyses were performed in LHS, and associations involving severe deficiency were externally validated in 223,000 propensity score-matched pairs from TriNetX. In both populations, severe deficiency was associated with increased risks across metabolic, cardiovascular, neurodegenerative, renal, microvascular, and mortality-related outcomes, including diabetes mellitus, myocardial infarction, cerebrovascular disease, dementia, dialysis, diabetic retinopathy, and foot/toe amputation. To assess the potential health benefits and modifiability of supplementation, we modeled vitamin D supplementation longitudinally using pharmacy-dispensed purchases calibrated to predict serum 25(OH)D changes over time. Supplementation was independently associated with dose-dependent reductions across mortality and multiple aging-related outcomes, while showing no corresponding protective association for skin malignancy, a negative-control outcome strongly linked to ultraviolet exposure. To strengthen causal interpretation, we additionally implemented inverse-probability-of-treatment-weighted marginal structural Cox models for mortality, which yielded results consistent with, and in several cases stronger than, conventional adjusted models. Together, these findings support severe vitamin D deficiency as an important and potentially modifiable determinant of systemic aging vulnerability and age-related multimorbidity in human populations.
- Open Access
Atovaquone-Proguanil and Reduced Digestive Cancer Risk: A Toxoplasma gondii Connection
Emerging evidence suggests microbial pathogens contribute to digestive cancer risk. Atovaquone–proguanil (A-P), an antimalarial with antiparasitic activity, has been associated with a reduced risk of colorectal cancer (CRC). We conducted a retrospective cohort study using the TriNetX US Collaborative Network, including over 100,000 individuals aged 40–69 years who received A-P, matched 1:1 to controls who received other medications. Incident digestive cancers were analyzed using Cox proportional hazards models. Additionally, we performed a metagenomic analysis of 1,044 fecal samples from 156 individuals to assess the abundance of Toxoplasma gondii in CRC-associated microbiota. A-P use was associated with a significant reduction in digestive cancer incidence across all age groups: hazard ratios (HRs) ranged from 0.49 to 0.53 (all PT. gondii was the most discriminatory microbial species for CRC (P=1.8×10 −16 ), detected above threshold in 22.6% of CRC samples versus 1.6% of controls (odds ratio 18.2, 95% CI, 8.2–47.6, P=2.3×10 −22 ). These findings suggest T. gondii may be an overlooked microbial risk factor for digestive cancers, and that A-P may offer chemopreventive effects through antiparasitic activity. Prospective studies are needed to evaluate its preventive potential.
Open AccessAtovaquone-Proguanil and Reduced Digestive Cancer Risk: A Toxoplasma gondii Connection
Emerging evidence suggests microbial pathogens contribute to digestive cancer risk. Atovaquone–proguanil (A-P), an antimalarial with antiparasitic activity, has been associated with a reduced risk of colorectal cancer (CRC). We conducted a retrospective cohort study using the TriNetX US Collaborative Network, including over 100,000 individuals aged 40–69 years who received A-P, matched 1:1 to controls who received other medications. Incident digestive cancers were analyzed using Cox proportional hazards models. Additionally, we performed a metagenomic analysis of 1,044 fecal samples from 156 individuals to assess the abundance of Toxoplasma gondii in CRC-associated microbiota. A-P use was associated with a significant reduction in digestive cancer incidence across all age groups: hazard ratios (HRs) ranged from 0.49 to 0.53 (all PT. gondii was the most discriminatory microbial species for CRC (P=1.8×10 −16 ), detected above threshold in 22.6% of CRC samples versus 1.6% of controls (odds ratio 18.2, 95% CI, 8.2–47.6, P=2.3×10 −22 ). These findings suggest T. gondii may be an overlooked microbial risk factor for digestive cancers, and that A-P may offer chemopreventive effects through antiparasitic activity. Prospective studies are needed to evaluate its preventive potential.